草药和其他传统药物治疗在全球范围内广泛使用。这种广泛使用提示传统药物具有良好的风险受益比,但并不确定,实际的风险与受益需要通过由现代临床科学原则支持并据此实施的临床试验来加以评价。一些国际组织和国家当局已发表声明,支持草药产品的临床试验,但是这些声明往往范围宽泛,且只使用本国语言。因此,WHO/TDR对评价草药产品诊断或治疗疾病的临床试验所必须的数据发布了简洁明确的建议。 Herbs and other traditional medical treatments are widely used worldwide. This widespread use suggests that traditional medicines have a good risk-benefit ratio, but it is not certain that actual risks and benefits need to be evaluated through clinical trials supported by and implemented by modern clinical science principles. A number of international organizations and national authorities have issued statements in support of clinical trials of herbal products, but these statements are often broad in scope and use only the native language. Therefore, WHO / TDR issued concise and clear recommendations on the data necessary to evaluate the clinical trials of herbal products in the diagnosis or treatment of disease.